Nasonex and Apathy - a phase IV clinical study of FDA data

Summary:

Apathy is reported as a side effect among people who take Nasonex (mometasone furoate monohydrate), especially for people who are male, 10-19 old, also take Ativan, and have Depression.

The phase IV clinical study analyzes which people have Apathy when taking Nasonex. It is created by eHealthMe based on reports of 31,171 people who have side effects when taking Nasonex from the FDA, and is updated regularly.

What is Nasonex?

Nasonex has active ingredients of mometasone furoate monohydrate. It is often used in allergies. eHealthMe is studying from 32,299 Nasonex users. Check the latest studies of Nasonex.

What is Apathy?

Apathy is found to be associated with 801 drugs and 1,164 conditions by eHealthMe. Check the latest studies of Apathy.

On Aug, 05, 2026

31,171 people reported to have side effects when taking Nasonex.
Among them, 25 people (0.08%) have Apathy.

Among these 25 people:

What is the gender of people who have Apathy when taking Nasonex? *

female: 39.13 %
male: 60.87 %

What is the age of people who have Apathy when taking Nasonex? *

What are other drugs people take besides Nasonex? *

What are other side effects people have besides Apathy? *

Insomnia (sleeplessness): 11 people, 44.00%
Stress And Anxiety: 11 people, 44.00%
Weakness: 10 people, 40.00%
Crying: 9 people, 36.00%
Depression: 9 people, 36.00%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 9 people, 36.00%
Disturbance In Attention: 8 people, 32.00%
Memory Loss: 8 people, 32.00%
Completed Suicide (act of taking one's own life): 7 people, 28.00%
Cardiac Arrest: 7 people, 28.00%

What are the existing conditions these people have? *

Depression: 13 people, 52.00%
Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 3 people, 12.00%
Bipolar Disorder (mood disorder): 2 people, 8.00%
Osteoporosis (bones weak and more likely to break): 2 people, 8.00%
Stress And Anxiety: 2 people, 8.00%
Hyperchlorhydria (gastric acid levels are higher in stomach): 1 person, 4.00%
Breakthrough Pain: 1 person, 4.00%
Cardiac Disorder: 1 person, 4.00%
Cystic Fibrosis (disease of the secretary glands): 1 person, 4.00%
Diarrhea: 1 person, 4.00%

* Approximation only. Some reports may have incomplete information.

Do you take Nasonex and have Apathy?

- Check whether Apathy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nasonex:

Nasonex (32,299 reports)

Apathy treatments and more:

Apathy (16,905 reports)

How severe was Apathy and when was it recovered:

Apathy in Nasonex

Expand to all the drugs that have ingredients of mometasone furoate monohydrate:

Apathy and drugs with ingredients of mometasone furoate monohydrate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Nasonex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Apathy:

Apathy (801 drugs)

Browse all the conditions that are associated with Apathy:

Apathy (1,164 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mometasone furoate monohydrate (the active ingredients of Nasonex) and Nasonex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.